[English] 日本語
Yorodumi- PDB-38pm: Australian bat lyssavirus glycoprotein PH domain in complex with ... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 38pm | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Australian bat lyssavirus glycoprotein PH domain in complex with broadly neutralizing human antibodies A6 and RVC20 | |||||||||
Components |
| |||||||||
Keywords | VIRAL PROTEIN / ABVL / PHD / antibody / neutralizing | |||||||||
| Function / homology | : / Rhabdovirus glycoprotein G PH domain / : / Rhabdovirus spike glycoprotein G central domain / Rhabdovirus glycoprotein / Rhabdovirus spike glycoprotein fusion domain / viral envelope / virion membrane / Glycoprotein Function and homology information | |||||||||
| Biological species | Homo sapiens (human) Lyssavirus australis | |||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.6 Å | |||||||||
Authors | Xu, K. / Xu, Y. | |||||||||
| Funding support | United States, 1items
| |||||||||
Citation | Journal: Emerg Microbes Infect / Year: 2026Title: Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection. Authors: Celeste Huaman / Yan Xu / Nathaniel M Lott / Elise M Santorella / Madeline Rader / Allison M Strazzella / Caitlyn Clouse / Jocelyn M King / Mattie Melnyk / Junping Hong / Lianying Yan / ...Authors: Celeste Huaman / Yan Xu / Nathaniel M Lott / Elise M Santorella / Madeline Rader / Allison M Strazzella / Caitlyn Clouse / Jocelyn M King / Mattie Melnyk / Junping Hong / Lianying Yan / Adrian C Paskey / Andrea E Luquette / Francisco Malagon / Regina Z Cer / Kimberly A Bishop-Lilly / Daniel P Perl / Christopher C Broder / Kai Xu / Brian C Schaefer / ![]() Abstract: Rabies is a fatal encephalitis caused by viruses in the lyssavirus genus. We previously demonstrated that intraperitoneal administration of a single dose of neutralizing human monoclonal antibody ...Rabies is a fatal encephalitis caused by viruses in the lyssavirus genus. We previously demonstrated that intraperitoneal administration of a single dose of neutralizing human monoclonal antibody (mAb) F11 can protect mice from fatal lyssavirus infection, post-central nervous system (CNS) invasion. However, the molecular basis of F11 neutralization remains unknown. Here, we use structural and functional analyses to define neutralizing activity of F11 and the related mAb, A6. Cryo-electron microscopy (EM) and negative-stain EM reveal that both mAbs bind Domain III of the glycoprotein G, recognizing a prefusion-specific epitope distinct from previously characterized antibodies including RVC20. Binding stabilizes the prefusion state, blocking membrane fusion. We furthermore found that a single dose of either A6 or RVC20 protected animals from mortality induced by Australian bat lyssavirus (ABLV), while promoting substantial long-term functional recovery. Moreover, A6 similarly protected animals from mortality following infection with a currently circulating wild isolate of rabies virus (RABV). Transcriptomics analysis of brain RNA and protein-based analysis of brain tissue homogenates demonstrated that therapy with A6 broadly reduced expression of neuroinflammatory mediators during the acute phase of infection. Interestingly, infection of animals with a non-lethal attenuated mutant of ABLV resulted in similar neuroinflammation. Thus, a robust neuroinflammatory response to ABLV does not predict mortality. Overall, peripheral therapy with A6 and similar neutralizing mAbs promotes survival and long-term functional recovery from CNS-resident lyssavirus infection in a manner that includes suppression of the G pre- to postfusion transition and modulation of neuroinflammation. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 38pm.cif.gz | 107.5 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb38pm.ent.gz | 80.5 KB | Display | PDB format |
| PDBx/mmJSON format | 38pm.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/8p/38pm ftp://data.pdbj.org/pub/pdb/validation_reports/8p/38pm | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 79039MC M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
| #1: Antibody | Mass: 13627.051 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) |
|---|---|
| #2: Antibody | Mass: 11523.791 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) |
| #3: Antibody | Mass: 14091.765 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) |
| #4: Antibody | Mass: 11441.696 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Production host: Homo sapiens (human) |
| #5: Protein | Mass: 10483.997 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Lyssavirus australis / Production host: Homo sapiens (human) / References: UniProt: Q9QSP1 |
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Lyssavirus australis / Type: VIRUS / Entity ID: all / Source: MULTIPLE SOURCES |
|---|---|
| Source (natural) | Organism: Lyssavirus australis |
| Source (recombinant) | Organism: Homo sapiens (human) |
| Details of virus | Empty: NO / Enveloped: YES / Isolate: STRAIN / Type: VIRION |
| Buffer solution | pH: 7.2 / Details: 5mM HEPES buffer pH7.2, 150nM NaCl |
| Specimen | Conc.: 1 mg/ml / Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES Details: 1mg/ml in HBS buffer, purfied from HEK293 recombinant expression and purified with NiNTA resin via Hisx6 tag |
| Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE / Humidity: 95 % / Chamber temperature: 273 K |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: OTHER |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 25000 nm / Nominal defocus min: 8000 nm / Calibrated defocus min: 1500 nm / Calibrated defocus max: 30000 nm |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: GATAN K3 BIOCONTINUUM (6k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.6 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 195885 / Symmetry type: POINT | ||||||||||||||||||||||||
| Refinement | Highest resolution: 3.6 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi



Homo sapiens (human)
Lyssavirus australis
United States, 1items
Citation
PDBj



FIELD EMISSION GUN